| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984635 Dimerizing agents, their production and use |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | US6984633 Administering a combination of drugs including an angiotensin II receptor agonist (a tetrazole or triazole derivative) and an epoxysteroidal aldosterone receptor antagonist (an epoxy containing compound) as anticardiofibrosis agent |
| 01/10/2006 | US6984632 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
| 01/10/2006 | US6984631 Thermoplastic cellulose derivative composition and fiber comprising the same |
| 01/10/2006 | US6984630 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection |
| 01/10/2006 | US6984629 Such as uridine 5'-diphosphoric acid for corneal epithelial migration promotion |
| 01/10/2006 | US6984628 Ophthalmic compositions comprising trefoil factor family peptides |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984624 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 01/10/2006 | US6984621 Wound contraction inhibitor |
| 01/10/2006 | US6984619 Method for protection against tumor metastasis formation |
| 01/10/2006 | US6984496 Vitro assay for testing gabapentinoid activity |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984403 Azithromycin dosage forms with reduced side effects |
| 01/10/2006 | US6984402 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/10/2006 | US6984400 Method of treating restenosis using bisphosphonate nanoparticles |
| 01/10/2006 | US6984397 Encapsulated pipecolic acid; immunosuppressants |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | US6984391 Mixture containing ammonium salt; gradient adjustment of pH; skin disorders, acne |
| 01/10/2006 | US6984389 Administering to a cancer patient at least one treatment modality, containing a tyrosine kinase inhibitor and a purified heat shock protein to cure the cancer |
| 01/10/2006 | US6984385 Immunological combination compositions and methods |
| 01/10/2006 | US6984128 Methods for enabling and stabilizing tooth movement |
| 01/10/2006 | US6983612 Process for producing phenothiazine granules |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2383036C Solid lipid formulations |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/10/2006 | CA2372206C Novel crystalline forms of a macrolide antibiotic |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364906C 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2351620C Nano-emulsion of 5-aminolevulinic acid |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/10/2006 | CA2298549C Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 01/10/2006 | CA2297764C Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia |
| 01/10/2006 | CA2268157C Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 01/10/2006 | CA2262252C Method of treating heart failure |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/10/2006 | CA2214033C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 01/10/2006 | CA2198630C Acetaminophen sustained-release formulation |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/10/2006 | CA2177970C Plaster containing an active substance |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/10/2006 | CA2157590C Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/10/2006 | CA2097997C Vitamin d compounds and method of preparing these compounds |
| 01/09/2006 | CA2474442A1 Cancer treatment resistance and agents modulating such resistance |
| 01/07/2006 | CA2511642A1 Compositions containing anti-acne agents and the use thereof |
| 01/06/2006 | CA2471063A1 Novel tfiih subunit |
| 01/05/2006 | WO2006002441A1 Phenothiazine derivatives and their method of use |
| 01/05/2006 | WO2006002434A2 Novel indazole carboxamides and their use |
| 01/05/2006 | WO2006002422A2 Compounds for immunopotentiation |
| 01/05/2006 | WO2006002416A2 Methods and means for increasing resistance to cell damage |
| 01/05/2006 | WO2006002375A2 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 01/05/2006 | WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals |
| 01/05/2006 | WO2006002287A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
| 01/05/2006 | WO2006002248A1 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/05/2006 | WO2006002233A2 Alvaradoins e-n, new antitumor and cytotoxic anthracenone g-glycosides |
| 01/05/2006 | WO2006002160A1 Vaccination of skunks and/or mongooses against rabies |
| 01/05/2006 | WO2006002121A2 Compounds and methods for treating seizure and paroxysmal disorders |
| 01/05/2006 | WO2006002117A1 Lactam tachykinin receptor antagonists |
| 01/05/2006 | WO2006002106A2 Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 01/05/2006 | WO2006002102A2 Spirocyclic compounds useful as modulators of nuclear hormone receptor function |
| 01/05/2006 | WO2006002099A2 Factor xa inhibitors |
| 01/05/2006 | WO2006002097A2 Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| 01/05/2006 | WO2006002088A2 Amino-quinazoline derivatives as antitumor agents |
| 01/05/2006 | WO2006002082A2 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 01/05/2006 | WO2006002073A2 Method for preventing heme-induced lipid peroxidation |
| 01/05/2006 | WO2006002067A1 Composition and method using local application of lipophilic lathyrogens in sustained release formulations |
| 01/05/2006 | WO2006002050A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | WO2006002047A2 Antibacterial agents |
| 01/05/2006 | WO2006002032A1 Sustained release neutralized divalproex sodium |
| 01/05/2006 | WO2006002022A2 Compositions and methods useful for the treatment of hyperglycemia |
| 01/05/2006 | WO2006001982A2 Methods and compositions for treating neuropathies |
| 01/05/2006 | WO2006001967A2 Migrastatin analogs in the treatment of cancer |
| 01/05/2006 | WO2006001963A1 Pharmaceutical compositions comprising cyclosporins |
| 01/05/2006 | WO2006001961A2 Compositions and methods relating to pyrimidine synthesis inhibitors |
| 01/05/2006 | WO2006001894A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/05/2006 | WO2006001888A2 Compositions and methods for inhibiting angiogenesis |
| 01/05/2006 | WO2006001866A2 Crystalline forms of n-desmethylclozapine |
| 01/05/2006 | WO2006001846A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| 01/05/2006 | WO2006001844A2 β-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST ANTHRAX LETHAL TOXIN |
| 01/05/2006 | WO2006001733A1 Tuberculosis treating and preventing agent |
| 01/05/2006 | WO2006001567A1 Poly-gamma-glutamic acid-vitamin complex and use thereof |
| 01/05/2006 | WO2006001471A1 Medicinal composition for promoting glucose-responsive insulin secretion |
| 01/05/2006 | WO2006001035A2 Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof. |
| 01/05/2006 | WO2006000922A2 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| 01/05/2006 | WO2006000914A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | WO2006000912A2 Pyridyl piperazines for the treatment of cns disorders |
| 01/05/2006 | WO2006000903A2 Use of reboxetine for the treatment of pain |
| 01/05/2006 | WO2006000867A1 Compositions for topical treatment |
| 01/05/2006 | WO2006000765A1 Novel uses |
| 01/05/2006 | WO2006000756A1 Sanitizing composition |
| 01/05/2006 | WO2006000577A2 Lxr agonists to promote bone homeostasis |